LearnGlossaryMarketStocksSuperinvestorsSign in

INSP

Inspire Medical Systems, Inc.

Healthcare · $2.1B market cap

Verdict

We can't put a fair value on INSP right now. It has fewer than 5 profitable years and uneven cash flow, not enough history to project from yet.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth175.7% a year✓
Equity per share growth28.6% a year✓
Sales growth53.2% a year✓
Free cash flow growth-13.9% a year✗
Return on invested capital1.4%✗

Follow INSP

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds INSP right now. In Q1 2026, 1 sold out. Who we track

Moves in Q1 2026

Sold out: Mairs & Power Funds

Insider activity

Since Aug 31, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

Kelly Jason P

See Remarks · 2026-08-31

Award

6,350 shares

About Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works